首页> 外文期刊>Nature >Structure of human O-GlcNAc transferase and its complex with a peptide substrate
【24h】

Structure of human O-GlcNAc transferase and its complex with a peptide substrate

机译:人O-GlcNAc转移酶的结构及其与肽底物的复合物

获取原文
获取原文并翻译 | 示例
           

摘要

The essential mammalian enzyme O-linked β-N-acetylglucosa-mine transferase (O-GlcNAc transferase, here OGT) couples metabolic status to the regulation of a wide variety of cellular signalling pathways by acting as a nutrient sensor. OGT catalyses the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine (UDP-GlcNAc) to serines and threonines of cytoplasmic, nuclear and mito-chondrial proteins, including numerous transcription factors, tumour suppressors, kinases, phosphatases and histone-modifying proteins. Aberrant glycosylation by OGT has been linked to insulin resistance, diabetic complications, cancer and neurodegenerative diseases including Alzheimer's. Despite the importance of OGT, the details of how it recognizes and glycosylates its protein substrates are largely unknown. We report here two crystal structures of human OGT, as a binary complex with UDP (2.8 A resolution) and as a ternary complex with UDP and a peptide substrate (1.95 A). The structures provide clues to the enzyme mechanism, show how OGT recognizes target peptide sequences, and reveal the fold of the unique domain between the two halves of the catalytic region. This information will accelerate the rational design of biological experiments to investigate OGT's functions; it will also help the design of inhibitors for use as cellular probes and help to assess its potential as a therapeutic target.
机译:必需的哺乳动物酶O连接的β-N-乙酰氨基葡萄糖转移酶(O-GlcNAc转移酶,此处为OGT)通过充当营养传感器将代谢状态与多种细胞信号通路的调节结合起来。 OGT催化N-乙酰氨基葡萄糖从UDP-N-乙酰氨基葡萄糖(UDP-GlcNAc)转移到胞质,核和线粒体蛋白的丝氨酸和苏氨酸,包括许多转录因子,肿瘤抑制因子,激酶,磷酸酶和组蛋白修饰蛋白。 OGT的异常糖基化与胰岛素抵抗,糖尿病并发症,癌症和神经退行性疾病(包括阿尔茨海默氏病)有关。尽管OGT非常重要,但如何识别和糖基化其蛋白质底物的细节仍然未知。我们在这里报告人类OGT的两个晶体结构,与UDP的二元复合物(2.8 A分辨率)和与UDP和肽底物的三元复合物(1.95 A)。这些结构为酶机制提供了线索,显示了OGT如何识别目标肽序列,并揭示了催化区域两半之间独特结构域的折叠。这些信息将加速生物学实验的合理设计,以研究OGT的功能;它还将有助于设计用作细胞探针的抑制剂,并有助于评估其作为治疗靶标的潜力。

著录项

  • 来源
    《Nature》 |2011年第7331期|p.564-567|共4页
  • 作者单位

    Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA,Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA,Laboratory of Molecular Medicine, Children's Hospital, Boston, Massachusetts 02115, USA;

    Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

    Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA,Laboratory of Molecular Medicine, Children's Hospital, Boston, Massachusetts 02115, USA;

    Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号